Integrated Filing — IndAS



General information about company
Scrip Code 532843
NSE Symbol FORTIS
MSEI Symbol NOTLISTED
ISIN INE061F01013
Name of company Fortis Healthcare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 06-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 30-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 06-Aug-2025   12:00:00
End date and time of board meeting 06-Aug-2025   20:25:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 21667200000
Other income 154000000
Total income 21821200000
2 Expenses
(a) Cost of materials consumed 0
(b) Purchases of stock-in-trade 5178600000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -37600000
(d) Employee benefit expense 3127500000
(e) Finance costs 695700000
(f) Depreciation, depletion and amortisation expense 1014800000
(f) Other Expenses
1 Professional and consultation fees to Doctors 4611000000 4611000000
2 Other Expenses 3881000000 3881000000
Total other expenses 8492000000
Total expenses 18471000000
3 Total profit before exceptional items and tax 3350200000
4 Exceptional items 126300000
5 Total profit before tax 3476500000
6 Tax expense
7 Current tax 399400000
8 Deferred tax 438500000
9 Total tax expenses 837900000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 2638600000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 29200000
16 Total profit (loss) for period 2667800000
17 Other comprehensive income net of taxes -4500000
18 Total Comprehensive Income for the period 2663300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 2602800000
Total profit or loss, attributable to non-controlling interests 65000000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 2598900000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 64400000
21 Details of equity share capital
Paid-up equity share capital 7549600000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.45
Diluted earnings (loss) per share from continuing operations 3.45
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.45
Diluted earnings (loss) per share from continuing and discontinued operations 3.45
24 Debt equity ratio 0.0028
25 Debt service coverage ratio 0.0592
26 Interest service coverage ratio 0.0732
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Healthcare 18378300000 18378300000
2 Diagnostic 3688200000 3688200000
3 Inter segment 0 0
Total Segment Revenue 22066500000
Less: Inter segment revenue 399300000 399300000
Revenue from operations 21667200000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Healthcare 3332700000 3332700000
2 Diagnostic 559300000 559300000
3 Inter segment 0 0
Total Profit before tax 3892000000
i. Finance cost 695700000 695700000
ii. Other Unallocable Expenditure net off Unallocable income -309400000 -309400000
Profit before tax 3505700000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Healthcare 102895000000 102895000000
2 Diagnostic 21258100000 21258100000
3 Inter segment -448400000 -448400000
Total Segment Asset 123704700000 123704700000
Un-allocable Assets 17565100000 17565100000
Net Segment Asset 141269800000 141269800000
4 Segment Liabilities
Segment Liabilities
1 Healthcare 13819600000 13819600000
2 Diagnostic 4377200000 4377200000
3 Inter segment -448400000 -448400000
Total Segment Liabilities 17748400000 17748400000
Un-allocable Liabilities 29164200000 29164200000
Net Segment Liabilities 46912600000 46912600000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss -30500000 -30500000
Total Amount of items that will not be reclassified to profit and loss -30500000
2 Income tax relating to items that will not be reclassified to profit or loss -6900000
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit or loss 19100000 19100000
Total Amount of items that will be reclassified to profit and loss 19100000
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income -4500000